SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Continental Home Healthcare -A Demographic Play -- Ignore unavailable to you. Want to Upgrade?


To: Edward W. Richmond who wrote (25)3/4/1999 2:07:00 PM
From: Edward W. Richmond  Read Replies (1) | Respond to of 69
 
CIMA, issued shares verses fully diluted shares
In post #26 I stated that there were 11,453,522 shares (fully diluted) when it should have been shares issued. When I realized my error, I contacted the company to get some indepth information.
If all warrants and options are exercised we would have 20,210,330 shares (fully diluted). The exercising of these warrants and options would provide the company with an additional cash of $8.4M. Obviously, the warrants, representing approximately 2.7M shares and with a conversion price of $1.81, will not likely be exercised. If they are, we will all do extremely well. However, I doubt that the stock price will exceed $1.81 in the near future. The warrants that I do expect to be exercised are the approximately 4.8M currently converting at $0.52 and in August change to $0.60. These are the ones that create the dilution that I don't particularly like. However, they will provide additional capital of approximately $2.5M to $2.9M depending upon when they are exercised. The options are priced from $0.80 TO $1.42. As such, they are above the current stock price.
I particularly like the very low debt level that CHT currently enjoys. This gives some flexibility in financing future acquisitions. A moderate amount of debt would certainly avoid any dilution concerns.
Regards, Ed